Over the last 12 months, one Cliffwater Enhanced Lending Fund officers and board members added shares in open-market trades, about $600,000 in total, and none of them sold.
Biggest single buyer: Worley Matthew Eugene, Director, with roughly $600,000.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Worley Matthew Eugene | Director | Buy | 54,645 | $10.98 | $600K | SEC |
| Jul 14, 2025 | Nesbitt Stephen Lane | President | Buy | 321,691 | $10.88 | $3.5M | SEC |
| May 9, 2025 | Nesbitt Stephen Lane | President | Buy | 1,948,811 | $10.93 | $21.3M | SEC |
| Nov 22, 2024 | Garcia Dominic Jerome | Director | Buy | 45,413 | $11.01 | $500K | SEC |
| Nov 24, 2023 | Nesbitt Stephen Lane | President | Buy | 1,207,591 | $10.82 | $13.1M | SEC |
| Nov 2, 2023 | Nesbitt Stephen Lane | President | Buy | 185,874 | $10.76 | $2.0M | SEC |
| Nov 2, 2023 | Nesbitt Stephen Lane | President | Buy | 185,874 | $10.76 | $2.0M | SEC |
| Oct 30, 2023 | Nesbitt Stephen Lane | President | Buy | 348,837 | $10.75 | $3.8M | SEC |
In the last 12 months Cliffwater Enhanced Lending Fund insiders made open-market purchases worth about $600,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CELFX was filed on 2026-03-20.
No congressional trades in CELFX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).